Navigation Links
Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP
Date:11/21/2007

e available on Rigel's website, in webcast and podcast formats, approximately 2 hours after the call.

Further information on ITP and R788 in ITP is available at Rigel's website: http://www.rigel.com/rigel/ITP.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the potential efficacy of Rigel's product candidates. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "plans," "intends," "indicates," "promising," "expects," "anticipates" and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with the timing and success of clinical trials and the commercialization of product candidates, as well as other risks detailed from time to time in Rigel's SEC reports, including its Fo
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Rigel Announces Third Quarter 2007 Financial Results
2. Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
3. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
6. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...mental and physical health , , MONDAY, N...ake as many years off your life as smoking does, a...f depression and anxiety appears to be better for ...ame to their conclusions after analyzing death rec...ng the four years after the survey, the death rate...
(Date:11/23/2009)... brain is regulated by a peptide known as C3a, whi...o nerve cells and is also important for the migrat...eveals new research from the Sahlgrenska Academy p... the research has been carried out using mice and ...r human beings, which could be given to patients w...
(Date:11/23/2009)...used Strategic Communications Agency Honored by As...nals , Salem, MA (PRWEB) ...focused strategic communications agency, announced...ward in the design/website homepage category admin... and Communication Professionals. The MarCom 2009 ...
(Date:11/23/2009)...e/--XiotechCorporationtodayannouncedthatMasonGener...agesystem,poweredbyIntelligentStorageElement(ISE(T...enablefuturegrowthanddeliversignificantcapitalando..., MasonGeneral,locatedinShelton,Wash.,wasratedoneo...d-Rural"hospitalsin2008and2009foritssuperioruseofi...
(Date:11/23/2009)...tandably captured the attention of public health o...alysis from Children,s Hospital Boston, based on p...ng several recent flu seasons, shows that another ...a substantially greater disease toll among young c...ata come from the pre-H1N1 influenza era, the anal...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3
...etic variations strongly associated with familial ...at Washington University School of Medicine in St.... and the United Kingdom. , The researchers found a...ot affected by whether the study participants smok...
...s in the United States undergo lung surgery each y...lity of their care. In the current issue of The A...ave proposed a system of lung surgery quality indi... are frequently reported. However, because they ar...
...y hospitals still giving them to new moms , ... to a new study, the majority of East Coast hospit..., even though most major medical organizations opp... in 21 Eastern states and the District of Columbia...
...ows promising results in the treatment of a this c... (Vocus) September 9, 2008 -- A pilot animal...nshospital.org/az/Site1062/mainpageS1062P0.html [...f the defect while in utero, may help repair spina...
...CH, Fla., Sept. 9 Celsius Holdings,Inc. (OTC Bull...ition to,its board of directors. Mr. Geary Cotton ...rsons that Mr. Carl DeSantis has the right to name...own,a consumer products company, where he worked u...
...s good foods taste better, helps breads rise, crea... the safety of jams and jellies. But,did you know ... jellies can,also help heal wounds?, Sugar is one...ing powers. Sugar has been used to treat wounds ac...
Other Medicine News:Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3Health News:Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery 2Health News:Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 2Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 3Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 4Health News:Celsius Strengthens Board With Prior Rexall Sundown CFO 2Health News:Sugar's Healing Powers 2
(Date:11/23/2009)....23/PRNewswire-FirstCall/--AMICAS,Inc.(Nasdaq: AMC...s,todayannouncedthatitwillhighlightitsenterpriseim...tyofNorthAmerica(RSNA)annualmeetingfromNovember29t...nbooth#7124. ,, (Logo: http://www.newscom.com/c...ationalconversationabouthealthcarereform,thereisan...
(Date:11/23/2009)...wswire/--Reportlinker.comannouncesthatanewmarketre...ilizationSystems&Equipment-AGlobalMarketPerspe...0/Sterilization-Systems--Equipment---A-Global-Mark...medium=pr&utm_campaign=prnewswire ,, St...delyusedprocedure.Steamsterilizationmarketisstable...
(Date:11/23/2009)...wswire/--Reportlinker.comannouncesthatanewmarketre...erMonitoringSystems-AGlobalMarketReview ,, h...ing-Systems---A-Global-Market-Review.html#utm_sour...rnewswire ,, Cardiovascularmonitoringisextr...sneedtobecontinuouslymonitoredduringdiagnosticaswe...
Breaking Medicine Technology:AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5UNC expert 3A Better decision support tools needed for prostate cancer screening choice 58429 1UNC expert 3A Better decision support tools needed for prostate cancer screening choice 58429 2Orgasms sexual health and attitudes about female genitals 58425 1Orgasms sexual health and attitudes about female genitals 58425 2A pet in your life keeps the doctor away 10143 1A pet in your life keeps the doctor away 10143 2A pet in your life keeps the doctor away 10143 3
...Mechanism and Demonstrate Significant Tumor ...n Mice, PALO ALTO, Calif., April 14 Intradigm Co...ic RNA interference (RNAi),therapeutics, today ann...,s,RNAi Nanoplex (NPX) delivery technology platfor...fering RNAs (siRNAs) targeting both vascular,endot...
...rogen,Pharmaceuticals Limited (ASX: PGL) (Nasdaq: ...data on its patented PG500 series of compounds at ...h (AACR) meeting being held,in San Diego. The meet...nts,from around the world to discuss new and signi...auses, diagnosis, treatment and prevention of,canc...
Other Medicine Technology:Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models 2Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models 3PG500 Series Presented at the AACR Annual Meeting in San Diego 2
SCANLISA Anti-PR3 IgG
...gy relates to the ultrasensitive measurement of Ad... cells. ATP produced by the AK reaction is measur...ogy to microbiological identification techniques, ...eads, Acolyte can measure bacteria and yeasts fast...
...a differential medium designed for the direct dete...s are incorporated for the suppression of gram-neg...d yeast. S. aureus hydrolyzes the chromogenic subs... differentiation from other gram-positive organism...
...diagnostic test cleared by the FDA and by Health C...on by methicillin resistant Staphylococcus aureus ...-MRSA test results are available in about one hour... other methods that require two to five days. By d...
Medicine Products: